组氨酸磷酸酶在某些疾病发病中作用的研究进展

doi:10.16352/j.issn.1001-6325.2023.05.0817

基础医学与临床 ›› 2023, Vol. 43 ›› Issue (5): 817-821.doi: 10.16352/j.issn.1001-6325.2023.05.0817

组氨酸磷酸酶在某些疾病发病中作用的研究进展

国鸽, 刘春蕾^*

中国人民解放军总医院医学创新研究部转化医学研究中心,北京 100853

收稿日期:2021-12-17 修回日期:2022-06-29 出版日期:2023-05-05 发布日期:2023-04-26
通讯作者: ^*liuchunlei@plagh.org
基金资助:
国家自然科学基金(82101966)

Progress on the role of histidine phosphatase in the occurrence of some diseases

GUO Ge, LIU Chunlei^*

Translation Medicine Research Center, Medical Innovcation Research Division of Chinese People's Liberation Army General Hospital, Beijing 100853, China

Received:2021-12-17 Revised:2022-06-29 Online:2023-05-05 Published:2023-04-26
Contact: ^*liuchunlei@plagh.org

摘要/Abstract

摘要： 蛋白的磷酸化修饰参与调控多种生物学过程,组氨酸磷酸酶可以使含有磷酸化的组蛋白去磷酸化。组氨酸磷酸酶功能障碍会导致多种临床疾病的发生,如肿瘤、代谢性疾病等。本文分别从组氨酸磷酸酶的组成,组氨酸磷酸酶与临床疾病的联系进行简要综述,以期为疾病的预防和诊治提供新思路。

关键词: 组氨酸磷酸酶, 疾病

Abstract: Protein phosphorylation is involved in the regulation of a variety of biological processes. Histidine phosphatase dephosphorylates proteins containing histidine phosphorylation. Therefore, histidine phosphatase dysfunction can lead to the occurrence of a variety of clinical diseases, such as tumors, metabolic diseases, etc. This review summarizes the composition of histidine phosphatase, the relationship between histidine phosphatase and clinical diseases in orer to provide a new pathway for the clinical treatment of diseases.

Key words: histidine phosphatase, diseases

中图分类号:

R34
R730.2

国鸽, 刘春蕾. 组氨酸磷酸酶在某些疾病发病中作用的研究进展[J]. 基础医学与临床, 2023, 43(5): 817-821.

GUO Ge, LIU Chunlei. Progress on the role of histidine phosphatase in the occurrence of some diseases[J]. Basic & Clinical Medicine, 2023, 43(5): 817-821.

参考文献

[1]Cao PF, Zhang ML, Wang LJ, et al. miR-18a reactivates the Epstein-Barr virus through defective DNA damage response and promotes genomic instability in EBV-associated lymphomas[J]. BMC Cancer, 2018, 18:1293. doi: 10.1186/s12885-018-5205-9.
[2]哈提米汗·买买提,姑丽克孜·买买提热夏提,李俞霆,等.CBX7蛋白在宫颈癌中的表达及其临床意义[J].基础医学与临床,2022,42:721-725.
[3]Zheng J, Dai X, Chen H, et al. Down-regulation of LHPP in cervical cancer influences cell proliferation, metastasis and apoptosis by modulating AKT[J]. Biochem Biophys Res Commun, 2018, 503: 1108-1114.
[4]Wu F, Chen YL, Zhu JH, et al. LHPP suppresses proliferation, migration, and invasion and promotes apoptosis in pancreatic cancer[J]. Biosci Rep, 2020, 40: BSR20194142. doi: 10.1042/BSR20194142.
[5]Wang D, Ning ZY, Zhu ZF, et al. LHPP suppresses tumorigenesis of intrahepatic cholangiocarcinoma by inhibit-ing the TGFβ/smad signaling pathway[J]. Int J Biochem Cell Biol, 2021, 132: 105845-105854.
[6]Li CK, Yang JY, Wang W, et al. LHPP exerts a tumor-inhibiting role in glioblastoma via the downregulation of Akt and Wnt/β-catenin signaling[J]. J Bioenerg Biomembr, 2021, 53: 61-71.
[7]Li YS, Zhang X, Zhou XG, et al. LHPP suppresses bladder cancer cell proliferation and growth via inactivating AKT/p65 signaling pathway[J]. Biosci Rep, 2019, 39: BSR20182270. doi: 10.1042/BSR20182270.
[8]Xu A, Hao J, Zhang Z, et al. 14-kDa phosphohistidine phosphatase and its role in human lung cancer cell migration and invasion[J]. Lung Cancer, 2010, 67:48-56.
[9]Shen H, Yang P, Liu Q, et al. Nuclear expression and clinical significance of phosphohistidine phosphatase 1 in clear-cell renal cell carcinoma[J]. J Int Med Res, 2015, 43: 747-757.
[10]Ruiz K, Thaker TM, Agnew C, et al. Functional role of PGAM5 multimeric assemblies and their polymerization into filaments[J]. Nat Commun, 2019, 10: 531-547.
[11]Chang LC, Fan CW, Tseng WK, et al. The ratio of thioredoxin/Keap1 protein level is a predictor of distant metastasis in colorectal cancer[J]. Biomark Med, 2017, 11: 1103-1111.
[12]Xu W, Jing L, Wang Q, et al. Bax-PGAM5L-Drp1 complex isrequired for intrinsic apoptosis execution[J]. Oncotarget, 2015, 6: 30017-30034.
[13]罗燮, 曾粒, 袁磊. 代谢型谷氨酸受体5(mGluR5)调控白色脂肪细胞棕色化[J]. 基础医学与临床, 2021, 41: 38-43.
[14]Kang JA, Kang HS, Bae KH, et al. Roles of protein histidine phosphatase 1 (PHPT1) in brown adipocyte differentiation[J]. J Microbiol Biotechnol, 2020, 30: 306-312.
[15]Sugawara S. The mitochondrial protein PGAM5 suppresses energy consumption in brown adipocytes by repressing expression of uncoupling protein 1[J]. J Biol Chem, 2020, 295: 5588-5601.
[16]Liu XY, Xu CF, Xu LX, et al. Empagliflozin improves diabetic renal tubular injury by alleviating mitochondrial fission via AMPK/SP1/PGAM5 pathway[J]. Metabolism, 2020, 111: 154334-154344.
[17]Hippe HJ, Wolf NM, Abu-Taha I, et al. The interaction of nucleoside diphosphate kinase B with Gbetagamma dimers controls heterotrimeric G protein function[J]. Proc Natl Acad Sci U S A, 2009, 106: 16269-16274.
[18]Zhou XB, Feng YX, Sun Q, et al. Nucleoside diphosphate kinase B-activated intermediate conductance potassium channels are critical for neointima formation in mouse carotid arteries[J]. Arterioscler Thromb Vasc Biol, 2015, 35: 1852-1861.
[19]Buljubasic F, El-Battrawy I, Lan H, et al. Nucleoside diphosphate kinase B contributes to arrhythmogenesis in human-induced pluripotent stem cell-derived cardiomyo-cytes from a patient with arrhythmogenic right ventricular cardiomyopathy[J]. J Clin Med, 2020, 9: 486-502.
[20]Cui L, Wang F, Yin Z, et al. Effects of the LHPP gene polymorphism on the functional and structural changes of gray matter in major depressive disorder[J]. Quant Imaging Med Surg, 2020, 10: 257-268.
[21]Ganzleben I, He GW, Günther C, et al. PGAM5 is a key driver of mitochondrial dysfunction in experimental lung fibrosis[J]. Cell Mol Life Sci, 2019, 76: 4783-4794.
[22]Tresse E, Riera-Ponsati L, Jaberi E, et al. IFN-β rescues neurodegeneration by regulating mitochondrial fission via STAT5, PGAM5, and Drp1[J]. EMBO J, 2021, 40: e106868. doi: 10.15252/embj.2020106868.
[23]Yu B, Ma J, Li J, et al. Mitochondrial phosphatase PGAM5 modulates cellular senescence by regulating mitochondrial dynamics[J]. Nat Commun, 2020, 11: 2549-2566.
[24]Choi Y, Shin SH, Jung H, et al. Specific fluorescent probe for protein histidine phosphatase activity[J]. ACS Sens, 2019, 4: 1055-1062.

组氨酸磷酸酶在某些疾病发病中作用的研究进展

Progress on the role of histidine phosphatase in the occurrence of some diseases

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	吴毅毅, 张梅, 杨云云, 李亚强, 李静, 贺佳乐, 张伟丽. ARHGEF7遗传变异与颅内动脉瘤相关[J]. 基础医学与临床, 2023, 43(4): 576-582.
[2]	杜丰禾, 刘暴. 血管周围脂肪组织炎性反应促进动脉粥样硬化作用机制的研究进展[J]. 基础医学与临床, 2023, 43(4): 685-689.
[3]	丁雨, 吴艳, 卞涛. 中性粒细胞胞外诱捕网在肺部疾病中作用的研究进展[J]. 基础医学与临床, 2023, 43(3): 481-485.
[4]	秦玉春, 邝向东, 蔡林再, 谢景臣, 陈山. 双氢青蒿素减轻慢性阻塞性肺疾病(COPD)模型大鼠肺损伤[J]. 基础医学与临床, 2023, 43(3): 427-432.
[5]	徐倩, 段华, 甘露, 刘麒薇. RhoGTP酶活化蛋白在上皮细胞间质转化中作用的研究进展[J]. 基础医学与临床, 2023, 43(2): 301-305.
[6]	方思尹, 刘辰, 吴晋晖. 微管抑制剂在血管新生性疾病中的作用机制研究进展[J]. 基础医学与临床, 2023, 43(2): 327-331.
[7]	杨蕴钊, 石美涵, 周诚, 白雪源. 间充质干细胞在肾脏疾病治疗中的应用进展[J]. 基础医学与临床, 2023, 43(1): 30-37.
[8]	周嘉航, 陈鋆瑶, 曹红翠. 间充质干细胞移植治疗肝脏疾病的研究进展[J]. 基础医学与临床, 2023, 43(1): 12-20.
[9]	商利鹏, 刘国祥, 丁晓燕, 李冰, 赵春华, 李霄霞. 间充质干细胞在衰老相关疾病应用中的研究进展[J]. 基础医学与临床, 2023, 43(1): 38-45.
[10]	陈莉莉, 孙永红, 雷晓燕, 王建军, 陈星星, 鲍柏辛. 间充质干细胞外泌体治疗肺部疾病的研究进展[J]. 基础医学与临床, 2023, 43(1): 192-195.
[11]	王平, 徐作军, 徐凯峰. 肺多发结节囊性病变罕见原因结节性硬化症1例[J]. 基础医学与临床, 2022, 42(9): 1424-1427.
[12]	孙爱华, 赵艳秋, 王继灵. 老年慢性阻塞性肺部疾病急性加重期患者住院死亡的危险因素及预后[J]. 基础医学与临床, 2022, 42(9): 1414-1418.
[13]	马茜钰, 彭石, 张兆元, 张丹, 张锦. 盐皮质激素受体对心血管疾病影响的研究进展[J]. 基础医学与临床, 2022, 42(8): 1292-1296.
[14]	栾格, 王明, 王成硕, 张罗. 干扰素调节因子4(IRF4)在慢性炎性疾病中作用的研究进展[J]. 基础医学与临床, 2022, 42(7): 1119-1123.
[15]	郑凯, 任华亮, 张望德, 李春民. 单细胞RNA测序技术在主动脉扩张性疾病中的应用[J]. 基础医学与临床, 2022, 42(7): 1139-1143.